Ignite Creation Date:
2024-05-06 @ 1:09 PM
Last Modification Date:
2024-10-26 @ 1:09 PM
Study NCT ID:
NCT03945799
Status:
TERMINATED
Last Update Posted:
2022-08-31
First Post:
2019-05-09
Brief Title:
A Multicenter Study of Anlotinib in Hepatocellular Carcinoma HCC Patients at High Risk of Post Surgery Recurrence
Sponsor:
Zhejiang University
Organization:
Zhejiang University
Organization Data
Organization:
Zhejiang University
Class:
OTHER
Study ID:
KY2019-AHR-ZJU
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Zhejiang University
Lead Sponsor Class:
OTHER
Responsible Party:
Xiao Xu
Responsible Party Title:
Clinical Professor
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Zhejiang University
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Shulan Hangzhou Hospital | OTHER |
| West China Hospital | OTHER |
| Huashan Hospital | OTHER |
| Third Affiliated Hospital Sun Yat-Sen University | OTHER |
| The First Affiliated Hospital of Zhengzhou University | OTHER |
| The First Hospital of Jilin University | OTHER |
| Tianjin First Central Hospital | OTHER |
| Shanghai General Hospital Shanghai Jiao Tong University School of Medicine | OTHER |